Optical Imaging Market Worth $1.9 Billion by 2018

              Optical Imaging Market Worth $1.9 Billion by 2018

  PR Newswire

  DALLAS, March 1, 2013

DALLAS, March 1, 2013 /PRNewswire/ --

According to a new market research report " Optical Imaging Market (2013-2018)
 -  Technology Trends And Applications Of Optical Coherence Tomography
(OCT), Hyper Spectral Imaging (HSI), Near Infrared Spectroscopy (NIRS) And
Photo- Acoustic Tomography (PAT) In Clinical Diagnostics, Clinical Research
And Life Sciences With Market Landscape Analysis - Estimates Up To 2018
",published by MarketsandMarkets the value of Optical Imaging Technologies
Market was $915.75 Million in the year 2012 and is expected to reach $1.9
Billion by 2018, at an estimated CAGR of 11.37% from 2013 to 2018.


  *10 market data tables
  *36 figures
  *147 Slides and an in-depth Table of Content on "Optical Imaging
    Technologies Market "

Buy a copy of this report @
http://www.marketsandmarkets.com/Purchase/purchase_report1.asp?id=894 Early
buyers will receive 10% customization on  this  report .

The global healthcare industry is witnessing a shift in paradigm and is now
skewed towards non-invasive diagnostics and therapeutic procedures, which not
only cures serious illnesses, but also have fewer side effects. Optical
imaging is one such technology with a potential to revolutionize clinical
diagnostics and drug discovery in healthcare. The technology uses light to
assess optical properties of tissues, and have a great potential in the
diagnosis and treatment of chronic diseases.

Though optical imaging is still in the early phase of development, it offers a
number of important advantages over existing radiological imaging techniques.
Optical imaging procedures are non-invasive, uses no ionizing radiation and
offer significant cost savings than the conventional radiological
technologies. These technologies have an inherent capacity for improving
diagnostic resolution. A key driving force of Optical imaging techniques is
the technology application scope for easy access to visualize and image
in-depth structures of eye, surface tissues, mucosal membranes, the
gastrointestinal tract, and vascular systems facilitating better diagnostic
procedures in clinical medicine. They also enhance the drug discovery process
by enabling better imaging of tissues and other biological entities at the
molecular level in biomedical research. The other advantages of using optical
imaging include the technologies are operator and patient safety. In the
future, most of these technologies will gain widespread clinical acceptance
and find specific roles in the clinical medicine.

This research service classifies optical Imaging technologies into Optical
Coherence Tomography (OCT), Photo-Acoustic Tomography (PAT), Hyperspectral
Imaging (HSI) and Near-Infrared Spectroscopy (NIRS). These technologies are
expected to drive the global optical imaging market for the coming five years.

Currently, the market of optical imaging is dominated by OCT with over 70% of
the market share and is expected to witness 4% CAGR growth by the end of 2018.
OCT is widely accepted for clinical diagnostics in ophthalmology, dentistry,
cardiology, dermatology and also has broadened its application in cancer
detection recently. Carl Zeiss and St. Jude Medical are the pioneers of this
technology and almost every set up comes with OCT technology. HSI, NIRS and
PAT are the emerging technologies in optical imaging market with a few players
in the market. HSI and NIRS are currently used for biomedical research and
drug discovery in the areas of dermatology and neurology. These technologies
are expected to grow exponentially, with a few units now readily available in
the market. Another emerging technology which recently made its entry into
market for cancer detection is the photo acoustic tomography (PAT). Recent
advances in PAT have made it possible to enhance its ability in recovering
both optical and acoustic properties that adds to its potential to better
differentiate benign from malignant lesions.

The global optical imaging market is poised to grow at a CAGR of 11.37% from
the year 2012 reaching approximately $1.9 billion by 2018. America is the
major market for optical imaging equipments followed by Europe and they have
been driving the market significantly owing to rising aging population in
these regions. Emerging economies such as Asia-pacific and Middle-East are the
future drivers of this market.

The main set-back of optical imaging market is lack of reimbursement coverage
. However, reimbursement policies would likely improve once these technologies
become more available.

The technology report identifies the potential market drivers and restraints
for analyzing the future technology trends, opportunities and overcoming the
challenges. The market segmentation, sizing and forecasts were made only for
the OCT technology and revenues are forecasted on the basis of major regions
such as North America and Europe Union. Further, the market is sub-segmented
based on OCT applications in clinical diagnostics - ophthalmology, dentistry,
dermatology, cardiology, neurology and oncology, clinical research- biomedical
research, drug discovery and therapeutic delivery, and life sciences- small
animal imaging and revenues were forecasted for the same.

The key players profiled in the report are Michelson Diagnostics, Heidelberg
Engineering GmBH, Carl Zeiss Meditec, Volcano Corporation, Topcon Medical
Systems Inc., St. Jude Medical Inc., Headwall Photonics, Cytoviva Inc.,
ChemImage Corporation, Bioptigen Inc., Raytheon ELCAN Optical Technologies,
Somanetics Corporation and ASE Optics Inc.

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in
the U.S. We publish strategically analyzed market research reports and serve
as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles,
databases, and custom research services. MarketsandMarkets covers thirteen
industry verticals; including advanced materials, automotives and
transportation, banking and financial services, biotechnology, chemicals,
consumer goods, telecommunications and IT, energy and power, food and
beverages, industrial automation, medical  devices , pharmaceuticals,
semiconductor and electronics.

We at MarketsandMarkets are inspired to help our clients grow by providing apt
business insight with our huge market intelligence repository.

Contact: Mr.  Rohan North - Dominion Plaza, 17304 Preston Road, Suite 800,
Dallas, TX 75252 Tel: +1-888-6006-441 Email: sales@marketsandmarkets.com Visit
MarketsandMarkets Blog @ http://www.marketsandmarketsblog.com Visit our Google
plus Profile @ https://plus.google.com/113935125281262465077/posts Connect
with us on Facebook @ https://www.facebook.com/MarketsandMarkets
Press spacebar to pause and continue. Press esc to stop.